Our June newsletter features the new EPiC CVD dashboard, a Q&A list about the adalimumab funding changes, a bulletin on health managers and equity, and our new Focus magazine.
From The Team
This page provides the specific methodology used for each data story featured in EPiC CVD.
10 June 2022
Our May newsletter features a summary comparison of molnupiravir with nirmatrelvir/ritonavir (Paxlovid), a bulletin on Paxlovid, our CVD workbook, and a short animated video highlighting patients' thoughts on changing from Humira to Amgevita.
31 May 2022
This page provides the specific methodology used for each data story featured in EPiC Annual Prescribing Report.
29 April 2022
Our newsflash keeps you updated on our latest content, ensuring that you don't miss any of our resources between newsletters. View the latest newsflash here.
27 April 2022
Our April newsletter is all about EPiC! Following extensive engagement, we've redesigned the EPiC dashboard to make it easier to use. Read about what the cilazapril, diabetes and gout themes can offer you, and learn about the features and activities in EPiC.
20 April 2022
This page provides the specific methodology used for each data story featured in EPiC Gout.
13 April 2022
Our March newsletter covers the introduction of the COVID-19 treatment Paxlovid in New Zealand and highlights our latest educational content. You'll find new video, article, and bulletin resources covering CVD, Paxlovid, and the switch to Amgevita.
12 April 2022
This page provides the specific methodology used for each data story featured in EPiC Diabetes.
24 March 2022
This page provides the specific methodology used for each data story featured in EPiC Cilazapril.
24 March 2022
Our February newsletter keeps you up-to-date on our latest resources. Check out our biological medicines resource hub, Amgevita article, and our bulletin on cardiovascular disease.
1 March 2022